This approach uses alternating electric fields at specific frequencies and intensities to affect cancer cell division. Applicable conditions and treatment regimens must be distinguished by the individual device’s approval and the clinical study.

Alternating electric fields under specific conditions are being studied for their effects on tubulin assembly and cell division. See the electric field therapy research background for mechanisms and the conditions of external clinical studies.

Our system is designed to maximise electric field delivery to the tumour while minimising exposure to surrounding healthy tissue.
Key benefits include: Enhanced therapeutic effect: More precise and potent targeting of cancer cells.
Optimized patient experience: Better control of treatment parameters to improve comfort and reduce side effects, such as skin irritation.

We plan to initiate clinical trials in 2026.